Letter

What works in schizophrenia: Depot preparations may improve outcomes

BMJ 2006; 333 doi: 10.1136/bmj.333.7563.353 (Published 10 August 2006)
Cite this as: BMJ 2006;333:353.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter M Haddad, consultant psychiatrist (Peter.Haddad@bstmht.nhs.uk),
  2. Omair Niaz, specialist registrar in psychiatry
  1. Sheffield Care Trust, Fulwood House, Sheffield S10 3TG
  2. Bolton, Salford and Trafford Mental Health NHS Trust, Salford M30 0GT

    EDITOR—The study by Tiihonen et al indicates that antipsychotics are not equally effective in treating schizophrenia.1 After a first admission with schizophrenia, patients treated with clozapine, olanzapine, or perphenazine depot had substantially lower risks of readmission, and discontinuation of treatment for any reason, than patients treated with oral haloperidol.

    Credit: BSIP, PIKO/SPL

    The increased effectiveness of clozapine is understandable in terms of its superior …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular